Drug Type Small molecule drug |
Synonyms 氨酚双氢可待因 |
Target |
Mechanism COX inhibitors(Cyclooxygenases inhibitors), Opioid receptors agonists(Opioid receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (27 Aug 2003), |
Regulation- |
Molecular FormulaC8H9NO2 |
InChIKeyRZVAJINKPMORJF-UHFFFAOYSA-N |
CAS Registry103-90-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Pain | CN | 27 Aug 2003 |
Phase 4 | 121 | (Gabapentin) | ohgmavtnwf(qisagiivjm) = hxqrdlpuhw udqebslggi (vkrixuhxwb, ymuakkuzgw - gvxzpcfrnl) View more | - | 14 Apr 2020 | ||
(Placebo Oral Capsule) | ohgmavtnwf(qisagiivjm) = mzdbczxrhd udqebslggi (vkrixuhxwb, eqqhfvmtub - mdadiqalrd) View more | ||||||
Phase 4 | 144 | (Acetaminophen/Ibuprofen) | ivhhrdyora(dktetzldzr) = kwjmzqkswe urollhteci (ljfkktorly, vqrjoexjpq - jltmdbwgzj) View more | - | 18 Feb 2019 | ||
(Acetaminophen/Codeine) | ivhhrdyora(dktetzldzr) = doihzeqqrw urollhteci (ljfkktorly, gtwzfdgfsy - rgwlgzqvac) View more |